Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 3/20 | 0.31 |
| ▸ | DRD4 | P21917 | 3/20 | 0.31 |
| ▸ | DRD3 | P35462 | 3/20 | 0.31 |
| ▸ | PRKCG | P05129 | 1/20 | 0.31 |
| ▸ | PRKCB | P05771 | 1/20 | 0.31 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
| ▸ | PDE1A | P54750 | 1/20 | 0.30 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.30 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25784871 | 0.91 | DRD2 (0.34) | DRD2DRD4DRD3PDE1APDE1B | |
| SCHEMBL10360901 | 0.84 | DRD2 (0.36) | KCNH2DRD2DRD4DRD3 | |
| SCHEMBL26302607 | 0.80 | DRD2 (0.33) | DRD2DRD4DRD3 | |
| SCHEMBL25791832 | 0.78 | DRD2 (0.33) | DRD2DRD4DRD3 | |
| SCHEMBL19163915 | 0.75 | DRD2 (0.30) | DRD2DRD4DRD3 | |
| SCHEMBL26302597 | 0.74 | LRRK2 (0.34) | — | |
| SCHEMBL21626282 | 0.73 | DRD2 (0.34) | DRD2DRD4DRD3 | |
| SCHEMBL20682229 | 0.72 | KDM4E (0.33) | KCNH2DRD2DRD4DRD3 | |
| SCHEMBL25633371 | 0.71 | DRD2 (0.34) | DRD2DRD4DRD3 | |
| SCHEMBL16320942 | 0.70 | ALDH1A1 (0.37) | PRKCGPRKCBPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023230190-A1 | PYRIMIDINE BASED MODULATORS AND USES THEREOF | QUANTA THERAPEUTICS, INC. (US) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023154766-A1 | KRAS MODULATORS AND USES THEREOF | QUANTA THERAPEUTICS, INC. (US) | 2023-08-17 | — | — | WO | disclosed |